Related Experiment Video
Updated: Jan 31, 2026

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
Determinants of survival of common childhood cancers in Iran
Aliasghar Keramatinia1,2, Maryam Mohseny2, Mohammad Esmaeil Akbari1
1Cancer Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Insights
Childhood cancer mortality is influenced by age, cancer type, and treatment. Multidisciplinary care and absence of family history improve survival outcomes for pediatric cancer patients.
Area of Science:
- Pediatric Oncology
- Epidemiology
- Biostatistics
Background:
- Childhood cancer is a significant cause of child morbidity and mortality.
- Epidemiological and demographic data on pediatric cancers in Iran are crucial for understanding disease burden.
Purpose of the Study:
- To epidemiologically and demographically assess common cancers in children in Iran.
- To identify factors affecting mortality in pediatric cancer patients.
Main Methods:
- A cohort study involving 2232 pediatric cancer patients from 2007 to 2016.
- Data collected included age, gender, race, family history, treatment type, and cancer type.
- Cox regression model was used to analyze the effect of these factors on mortality.
Main Results:
- Age, race, cancer type, family history, and treatment significantly impacted mortality (P < 0.05).
- Higher mortality hazard ratios (HR) were observed in older children (10-15 years) and specific cancers like brain tumors, sarcoma, and neuroblastoma compared to leukemia.
- A family history of cancer increased mortality risk (HR = 1.33), while multidisciplinary treatments (chemotherapy with surgery and radiotherapy, or chemotherapy with surgery) reduced it (HR = 0.68 and 0.67, respectively).
Conclusions:
- Younger age, multidisciplinary treatment approaches, and no family history of cancer are associated with a lower risk of death.
- Certain cancers (brain tumor, sarcoma, neuroblastoma) present a higher mortality risk than leukemia.
- Regular follow-up for children with a family history of cancer and comprehensive, multidisciplinary treatment are recommended.
Background:
Cancer is the second most common cause of morbidity and mortality in children. This study aimed to epidemiologically and demographically assess common cancers in children in Iran.
Materials And Methods:
This cohort study was conducted on children registered in Mahak Hospital and Rehabilitation Complex (which is a non-governmental organizations (NGO)-related hospital for only malignant diseases). A total of 2232 questionnaires were filled out for cancer patients between 2007 and 2016. The factors including age, gender, race, family history, type of treatment, and type of cancer were entered into Cox regression model to examine their effect on mortality of children diagnosed with cancer.
Results:
The Cox regression model showed that age, race, type of cancer, family history of cancer, and type of treatment had a significant effect on mortality of children diagnosed with cancer (P < 0.05). The hazard ratio (HR) of mortality in 10-15 years old was higher than that of 1-5 years old (P = 0.03, HR = 1.3). The HR of mortality in patients with brain tumor (P < 0.01, HR = 2.24), sarcoma (P < 0.01, HR = 2.32), and neuroblastoma (P < 0.01, HR = 2.56) was twice the value in patients with leukemia. The HR of mortality in patients who had a family history of cancer was higher than that of patients without it (P < 0.01, HR = 1.33). Patients who had undergone chemotherapy along with surgery and radiotherapy (P = 0.02, HR = 0.68) and patients who received chemotherapy along with surgery (P = 0.01, HR = 0.67) had a lower HR of mortality compared to the chemotherapy group.
Conclusion:
Young age, multidisciplinary approach, and absence of family history were associated with lower hazard of death in children diagnosed with cancer; brain tumor, leukemia, and sarcoma had higher hazard of mortality compared to leukemia. Children with a family history of cancer should be under regular follow-up. Treatment should be multidisciplinary and comprehensive.
More Related Videos
Related Concept Videos
Cancer Survival Analysis
Common Ion Effect
Survival Curves
The Kaplan-Meier estimator is the most common method for constructing survival curves. This...
Survival Tree
Building a Survival Tree
Constructing a...
Introduction To Survival Analysis
The primary goal of survival analysis is to estimate survival time—the time...
Comparing the Survival Analysis of Two or More Groups

